BSRT Graduate School

Graduate School 203 of the DFG Excellence Initiative

Berlin-Brandenburg School for Regenerative Therapies

Programmes at the BSRT Lecture Series
alt alt

biothinking1

Doctoral Researchers  Postdoc Researchers  Clinical Scientists BioThinking  

The Berlin-Brandenburg School for Regenerative Therapies (BSRT, graduate school 203 of the German Excellence Initiative) offers interdisciplinary training and research opportunities in the field of Regenerative Medicine for outstanding doctoral and postdoctoral researchers with a background in the biological, engineering or clinical disciplines. Young scientists at the BSRT benefit from our worldwide unique approach to foster collaborative science (BioThinking) and work within a strong and intellectually stimulating network of institutions and scientists.

 

If you want to subscribe to our mailing list click here...

 

 

  Winners of the BSRT Student Award 2018
Dimitrios L. Wagner who is doing his MD/PhD at the the Charité is the winner of the PhD Student Award 2018 for his publication on "High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population" in Nature Medicine [Pubmed]. Regina Puts and Paul Rikeit jointly won second the price and Ann-Kathrin Schubert the third price. Click here for winners
 

 

  Graduation - Congratulation
Christopher Differ, who was BSRT student at the Berlin-Brandenburg Center for Regenerative Therapies defended his thesis on the 26 November 2018. His thesis was entitled "Taking NO for an answer: An investigation on the modulatory effects of the Nitric Oxide pathway on Bone Morphogenic Protein 2 signalling and osteoinductive potential".
 

 

  Winner of the 1st poster prize
The 1st prize for the best poster 2018 is awarded to Maria Eugenia Butini (PhD at the Charité - Universitätsmedizin Berlin) at the 37th Annual Meeting of the European Bone & Joint infections Society. Her poster title was "Daptomycin release from thermosensitive injectable hydrogels: favourable release kinetics for the management of implant-associated infections".